Exact Mass: 531.2264348
Exact Mass Matches: 531.2264348
Found 500 metabolites which its exact mass value is equals to given mass value 531.2264348
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Phaseolotoxin
Harringtonine
D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D006248 - Harringtonines relative retention time with respect to 9-anthracene Carboxylic Acid is 0.578 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.580 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.570 Harringtonine is a natural Cephalotaxus alkaloid that inhibits protein synthesis. Harringtonine has anti-chikungunya virus (CHIKV) activities with an EC50 of 0.24 μM. Harringtonine is a natural Cephalotaxus alkaloid that inhibits protein synthesis. Harringtonine has anti-chikungunya virus (CHIKV) activities with an EC50 of 0.24 μM.
Rupatadine Fumarate
C30H30ClN3O4 (531.1924730000001)
Rupatadine (UR-12592) Fumarate is a potent, orally active and long-lasting dual PAF/H1 antagonist, with Kis of 0.55 μM and 0.1 μM, respectively. Rupatadine Fumarate can be used for the research of allergic rhinitis and urticaria[1][2][3].
Petasinoside
Petasinoside is found in green vegetables. Petasinoside is an alkaloid from flower stalks of Petasites japonicus (sweet coltsfoot
Azeliragon
C78272 - Agent Affecting Nervous System
Alkaloid C from cephalotaxus
D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D006248 - Harringtonines Harringtonine is a natural Cephalotaxus alkaloid that inhibits protein synthesis. Harringtonine has anti-chikungunya virus (CHIKV) activities with an EC50 of 0.24 μM. Harringtonine is a natural Cephalotaxus alkaloid that inhibits protein synthesis. Harringtonine has anti-chikungunya virus (CHIKV) activities with an EC50 of 0.24 μM.
Mirodenafil
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor
3-[[2-(2-Benzoyl-N-[2-[(2-methylpropan-2-yl)oxy]-2-oxoethyl]anilino)-2-oxoethyl]carbamoylamino]benzoic acid
harringtonin
Harringtonine is an alkaloid. Harringtonine is a natural product found in Cephalotaxus harringtonia, Cephalotaxus fortunei, and Apis cerana with data available. D000970 - Antineoplastic Agents > D000972 - Antineoplastic Agents, Phytogenic > D006248 - Harringtonines Harringtonine is a natural Cephalotaxus alkaloid that inhibits protein synthesis. Harringtonine has anti-chikungunya virus (CHIKV) activities with an EC50 of 0.24 μM. Harringtonine is a natural Cephalotaxus alkaloid that inhibits protein synthesis. Harringtonine has anti-chikungunya virus (CHIKV) activities with an EC50 of 0.24 μM.
MIRODENAFIL
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor
Fluprostenol serinol amide
Val Arg Glu Glu
Asn His Phe Asp
Asn Phe His Asp
Arg Ile Glu Asp
Isoharringtonine
Isoharringtonine is a natural product found in Cephalotaxus harringtonia and Cephalotaxus fortunei with data available.
MK-547
CONFIDENCE standard compound; INTERNAL_ID 311; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5169; ORIGINAL_PRECURSOR_SCAN_NO 5165 CONFIDENCE standard compound; INTERNAL_ID 311; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5220; ORIGINAL_PRECURSOR_SCAN_NO 5219 CONFIDENCE standard compound; INTERNAL_ID 311; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5188; ORIGINAL_PRECURSOR_SCAN_NO 5186 CONFIDENCE standard compound; INTERNAL_ID 311; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5190; ORIGINAL_PRECURSOR_SCAN_NO 5188 CONFIDENCE standard compound; INTERNAL_ID 311; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5265; ORIGINAL_PRECURSOR_SCAN_NO 5263 CONFIDENCE standard compound; INTERNAL_ID 311; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5189; ORIGINAL_PRECURSOR_SCAN_NO 5186 CONFIDENCE standard compound; INTERNAL_ID 311; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9697; ORIGINAL_PRECURSOR_SCAN_NO 9696 CONFIDENCE standard compound; INTERNAL_ID 311; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9731; ORIGINAL_PRECURSOR_SCAN_NO 9727 CONFIDENCE standard compound; INTERNAL_ID 311; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9747; ORIGINAL_PRECURSOR_SCAN_NO 9745 CONFIDENCE standard compound; INTERNAL_ID 311; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9775; ORIGINAL_PRECURSOR_SCAN_NO 9772 CONFIDENCE standard compound; INTERNAL_ID 311; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9740; ORIGINAL_PRECURSOR_SCAN_NO 9738 CONFIDENCE standard compound; INTERNAL_ID 311; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9776; ORIGINAL_PRECURSOR_SCAN_NO 9774
Ala Gln Gln Trp
Ala Gln Trp Gln
Ala Trp Gln Gln
Cys His Ser Trp
Cys His Trp Ser
Cys Ser His Trp
Cys Ser Trp His
Cys Trp His Ser
Cys Trp Ser His
Asp Asp Pro Trp
C24H29N5O9 (531.1965184000001)
Asp Asp Trp Pro
C24H29N5O9 (531.1965184000001)
Asp Glu Ile Arg
Asp Glu Leu Arg
Asp Glu Arg Ile
Asp Glu Arg Leu
Asp Phe His Asn
Asp Phe Asn His
Asp His Phe Asn
Asp His Asn Phe
Asp Ile Glu Arg
Asp Ile Arg Glu
Asp Ile Val Trp
Asp Ile Trp Val
Asp Leu Glu Arg
Asp Leu Arg Glu
Asp Leu Val Trp
Asp Leu Trp Val
Asp Asn Phe His
Asp Asn His Phe
Asp Asn Gln Arg
Asp Asn Arg Gln
Asp Pro Asp Trp
C24H29N5O9 (531.1965184000001)
Asp Pro Trp Asp
C24H29N5O9 (531.1965184000001)
Asp Gln Asn Arg
Asp Gln Arg Asn
Asp Arg Glu Ile
Asp Arg Glu Leu
Asp Arg Ile Glu
Asp Arg Leu Glu
Asp Arg Asn Gln
Asp Arg Gln Asn
Asp Val Ile Trp
Asp Val Leu Trp
Asp Val Trp Ile
Asp Val Trp Leu
Asp Trp Asp Pro
C24H29N5O9 (531.1965184000001)
Asp Trp Ile Val
Asp Trp Leu Val
Asp Trp Pro Asp
C24H29N5O9 (531.1965184000001)
Asp Trp Val Ile
Asp Trp Val Leu
Glu Asp Ile Arg
Glu Asp Leu Arg
Glu Asp Arg Ile
Glu Asp Arg Leu
Glu Glu Arg Val
Glu Glu Val Arg
Glu Ile Asp Arg
Glu Ile Arg Asp
Glu Lys Gln Gln
Glu Leu Asp Arg
Glu Leu Arg Asp
Glu Met Pro Arg
Glu Met Arg Pro
Glu Asn Asn Arg
Glu Asn Arg Asn
Glu Pro Met Arg
Glu Pro Arg Met
Glu Pro Thr Trp
Glu Pro Trp Thr
Glu Gln Lys Gln
Glu Gln Gln Lys
Glu Gln Gln Gln
C20H33N7O10 (531.2288798000001)
Glu Arg Asp Ile
Glu Arg Asp Leu
Glu Arg Glu Val
Glu Arg Ile Asp
Glu Arg Leu Asp
Glu Arg Met Pro
Glu Arg Asn Asn
Glu Arg Pro Met
Glu Arg Val Glu
Glu Thr Pro Trp
Glu Thr Trp Pro
Glu Val Glu Arg
Glu Val Arg Glu
Glu Val Val Trp
Glu Val Trp Val
Glu Trp Pro Thr
Glu Trp Thr Pro
Glu Trp Val Val
Phe Asp His Asn
Phe Asp Asn His
Phe His Asp Asn
Phe His Asn Asp
Phe His Gln Thr
Phe His Thr Gln
Phe Asn Asp His
Phe Asn His Asp
Phe Gln His Thr
Phe Gln Thr His
Phe Thr His Gln
Phe Thr Gln His
Gly His Arg Tyr
Gly His Tyr Arg
Gly Asn Arg Trp
Gly Asn Trp Arg
Gly Arg His Tyr
Gly Arg Asn Trp
Gly Arg Trp Asn
Gly Arg Tyr His
Gly Trp Asn Arg
Gly Trp Arg Asn
Gly Tyr His Arg
Gly Tyr Arg His
His Cys Ser Trp
His Cys Trp Ser
His Asp Phe Asn
His Asp Asn Phe
His Phe Asp Asn
His Phe Asn Asp
His Phe Gln Thr
His Phe Thr Gln
His Gly Arg Tyr
His Gly Tyr Arg
His Met Met Asn
His Met Asn Met
His Asn Asp Phe
His Asn Phe Asp
His Asn Met Met
His Asn Val Tyr
His Asn Tyr Val
His Gln Phe Thr
His Gln Thr Phe
His Arg Gly Tyr
His Arg Tyr Gly
His Ser Cys Trp
His Ser Trp Cys
His Thr Phe Gln
His Thr Gln Phe
His Val Asn Tyr
His Val Tyr Asn
His Trp Cys Ser
His Trp Ser Cys
His Tyr Gly Arg
His Tyr Asn Val
His Tyr Arg Gly
His Tyr Val Asn
Ile Asp Glu Arg
Ile Asp Arg Glu
Ile Asp Val Trp
Ile Asp Trp Val
Ile Glu Asp Arg
Ile Glu Arg Asp
Ile Arg Asp Glu
Ile Arg Glu Asp
Ile Val Asp Trp
Ile Val Trp Asp
Ile Trp Asp Val
Ile Trp Val Asp
Lys Glu Gln Gln
Lys Gln Glu Gln
Lys Gln Gln Glu
Leu Asp Glu Arg
Leu Asp Arg Glu
Leu Asp Val Trp
Leu Asp Trp Val
Leu Glu Asp Arg
Leu Glu Arg Asp
Leu Arg Asp Glu
Leu Arg Glu Asp
Met Glu Pro Arg
Met Glu Arg Pro
Met His Met Asn
Met His Asn Met
Met Met His Asn
Met Met Asn His
Met Asn His Met
Met Asn Met His
Met Pro Glu Arg
Met Pro Arg Glu
Met Pro Val Trp
Met Pro Trp Val
Met Arg Glu Pro
Met Arg Pro Glu
Met Val Pro Trp
Met Val Trp Pro
Met Trp Pro Val
Met Trp Val Pro
Asn Asp Phe His
Asn Asp His Phe
Asn Asp Gln Arg
Asn Asp Arg Gln
Asn Glu Asn Arg
Asn Glu Arg Asn
Asn Phe Asp His
Asn Gly Arg Trp
Asn Gly Trp Arg
Asn His Asp Phe
Asn His Met Met
Asn His Val Tyr
Asn His Tyr Val
Asn Met His Met
Asn Met Met His
Asn Asn Glu Arg
Asn Asn Arg Glu
Asn Asn Val Trp
Asn Asn Trp Val
Asn Gln Asp Arg
Asn Gln Arg Asp
Asn Arg Asp Gln
Asn Arg Glu Asn
Asn Arg Gly Trp
Asn Arg Asn Glu
Asn Arg Gln Asp
Asn Arg Trp Gly
Asn Val His Tyr
Asn Val Asn Trp
Asn Val Trp Asn
Asn Val Tyr His
Asn Trp Gly Arg
Asn Trp Asn Val
Asn Trp Arg Gly
Asn Trp Val Asn
Asn Tyr His Val
Asn Tyr Val His
Pro Asp Asp Trp
C24H29N5O9 (531.1965184000001)
Pro Asp Trp Asp
C24H29N5O9 (531.1965184000001)
Pro Glu Met Arg
Pro Glu Arg Met
Pro Glu Thr Trp
Pro Glu Trp Thr
Pro Met Glu Arg
Pro Met Arg Glu
Pro Met Val Trp
Pro Met Trp Val
Pro Arg Glu Met
Pro Arg Met Glu
Pro Thr Glu Trp
Pro Thr Trp Glu
Pro Val Met Trp
Pro Val Trp Met
Pro Trp Asp Asp
C24H29N5O9 (531.1965184000001)
Pro Trp Glu Thr
Pro Trp Met Val
Pro Trp Thr Glu
Pro Trp Val Met
Gln Ala Gln Trp
Gln Ala Trp Gln
Gln Asp Asn Arg
Gln Asp Arg Asn
Gln Glu Lys Gln
Gln Glu Gln Lys
Gln Glu Gln Gln
C20H33N7O10 (531.2288798000001)
Gln Phe His Thr
Gln Phe Thr His
Gln His Phe Thr
Gln His Thr Phe
Gln Lys Glu Gln
Gln Lys Gln Glu
Gln Asn Asp Arg
Gln Asn Arg Asp
Gln Gln Ala Trp
Gln Gln Glu Lys
Gln Gln Glu Gln
C20H33N7O10 (531.2288798000001)
Gln Gln Lys Glu
Gln Gln Gln Glu
C20H33N7O10 (531.2288798000001)
Gln Gln Trp Ala
Gln Arg Asp Asn
Gln Arg Asn Asp
Gln Thr Phe His
Gln Thr His Phe
Gln Trp Ala Gln
Gln Trp Gln Ala
Arg Asp Glu Ile
Arg Asp Glu Leu
Arg Asp Ile Glu
Arg Asp Leu Glu
Arg Asp Asn Gln
Arg Asp Gln Asn
Arg Glu Asp Ile
Arg Glu Asp Leu
Arg Glu Glu Val
Arg Glu Ile Asp
Arg Glu Leu Asp
Arg Glu Met Pro
Arg Glu Asn Asn
Arg Glu Pro Met
Arg Glu Val Glu
Arg Gly His Tyr
Arg Gly Asn Trp
Arg Gly Trp Asn
Arg Gly Tyr His
Arg His Gly Tyr
Arg His Tyr Gly
Arg Ile Asp Glu
Arg Leu Asp Glu
Arg Leu Glu Asp
Arg Met Glu Pro
Arg Met Pro Glu
Arg Asn Asp Gln
Arg Asn Glu Asn
Arg Asn Gly Trp
Arg Asn Asn Glu
Arg Asn Gln Asp
Arg Asn Trp Gly
Arg Pro Glu Met
Arg Pro Met Glu
Arg Gln Asp Asn
Arg Gln Asn Asp
Arg Val Glu Glu
Arg Trp Gly Asn
Arg Trp Asn Gly
Arg Tyr Gly His
Arg Tyr His Gly
Ser Cys His Trp
Ser Cys Trp His
Ser His Cys Trp
Ser His Trp Cys
Ser Trp Cys His
Ser Trp His Cys
Thr Glu Pro Trp
Thr Glu Trp Pro
Thr Phe His Gln
Thr Phe Gln His
Thr His Phe Gln
Thr His Gln Phe
Thr Pro Glu Trp
Thr Pro Trp Glu
Thr Gln Phe His
Thr Gln His Phe
Thr Trp Glu Pro
Thr Trp Pro Glu
Val Glu Glu Arg
Val Glu Arg Glu
Val His Asn Tyr
Val His Tyr Asn
Val Met Pro Trp
Val Met Trp Pro
Val Asn His Tyr
Val Asn Asn Trp
Val Asn Trp Asn
Val Asn Tyr His
Val Pro Met Trp
Val Pro Trp Met
Val Trp Met Pro
Val Trp Asn Asn
Val Trp Pro Met
Val Tyr His Asn
Val Tyr Asn His
Trp Ala Gln Gln
Trp Cys His Ser
Trp Cys Ser His
Trp Asp Asp Pro
C24H29N5O9 (531.1965184000001)
Trp Asp Pro Asp
C24H29N5O9 (531.1965184000001)
Trp Glu Pro Thr
Trp Glu Thr Pro
Trp Gly Asn Arg
Trp Gly Arg Asn
Trp His Cys Ser
Trp His Ser Cys
Trp Met Pro Val
Trp Met Val Pro
Trp Asn Gly Arg
Trp Asn Asn Val
Trp Asn Arg Gly
Trp Asn Val Asn
Trp Pro Asp Asp
C24H29N5O9 (531.1965184000001)
Trp Pro Glu Thr
Trp Pro Met Val
Trp Pro Thr Glu
Trp Pro Val Met
Trp Gln Ala Gln
Trp Gln Gln Ala
Trp Arg Gly Asn
Trp Arg Asn Gly
Trp Ser Cys His
Trp Ser His Cys
Trp Thr Glu Pro
Trp Thr Pro Glu
Trp Val Met Pro
Trp Val Asn Asn
Trp Val Pro Met
Tyr Gly His Arg
Tyr Gly Arg His
Tyr His Gly Arg
Tyr His Asn Val
Tyr His Arg Gly
Tyr His Val Asn
Tyr Asn His Val
Tyr Asn Val His
Tyr Arg Gly His
Tyr Arg His Gly
Tyr Val His Asn
Tyr Val Asn His
Petasinoside
TERT-BUTYL (5-(6-(BENZYLOXY)-5-(TRIFLUOROMETHYL)NAPHTHALEN-2-YL)-2,2-DIMETHYL-1,3-DIOXAN-5-YL)CARBAMATE
2-[4-(2-{2-cyclopentyl-5-[(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl]-4-hydroxy-6-oxo-3,6-dihydro-2H-pyran-2-yl}ethyl)-2-fluorophenyl]-2-methylpropanenitrile
butropium bromide
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
1H-Indole-2-carboxylic acid, 1-((3,5-bis(2-methoxyethoxy)phenyl)methyl)-3-(4-(1,1-dimethylethyl)phenyl)-
5-Chloro-4-(1H-indol-3-yl)-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidin-2-amine
5H-Cyclopenta(b)pyridine-6-carboxylic acid, 5-(1,3-benzodioxol-5-yl)-2-butyl-7-(2-((2S)-2-carboxypropyl)-4-methoxyphenyl)-6,7-dihydro-, (5S,6R,7R)-
D065128 - Endothelin Receptor Antagonists
methyl (2S,3R,4S)-3-ethenyl-4-[[(1S)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-2-ium-1-yl]methyl]-2-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylate
[(2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(aminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-3-yl] dihydrogen phosphate
N-[(5S)-5-acetamido-6-methoxy-6-oxohexyl]-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]phosphonamidic acid
3alpha(S)-strictosidinium(1+)
Conjugate base of 3alpha(S)-strictosidine arising from protonation of the secondary amino group; major species at pH 7.3.
(3-fluorophenyl)-[(1R)-2-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanone
3-(2-fluorophenyl)-1-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C27H34FN3O5S (531.2203086000001)
3-(2-fluorophenyl)-1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C27H34FN3O5S (531.2203086000001)
3-(2-fluorophenyl)-1-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C27H34FN3O5S (531.2203086000001)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
C30H33N3O6 (531.2369238000001)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
C30H33N3O6 (531.2369238000001)
3-(2-fluorophenyl)-1-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C27H34FN3O5S (531.2203086000001)
3-(2-fluorophenyl)-1-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C27H34FN3O5S (531.2203086000001)
3-(2-fluorophenyl)-1-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C27H34FN3O5S (531.2203086000001)
3-(2-fluorophenyl)-1-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C27H34FN3O5S (531.2203086000001)
3-(2-fluorophenyl)-1-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-pent-1-ynyl-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
C27H34FN3O5S (531.2203086000001)
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(4-methoxyphenyl)carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
C30H33N3O6 (531.2369238000001)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
C30H33N3O6 (531.2369238000001)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
C30H33N3O6 (531.2369238000001)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C30H33N3O6 (531.2369238000001)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C30H33N3O6 (531.2369238000001)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C30H33N3O6 (531.2369238000001)
[(1S)-7-methoxy-9-methyl-1-(4-methylphenyl)sulfonyl-2-(phenylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
C30H33N3O6 (531.2369238000001)
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
C30H33N3O6 (531.2369238000001)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C30H33N3O6 (531.2369238000001)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C30H33N3O6 (531.2369238000001)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[(4-methoxyanilino)-oxomethyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
C30H33N3O6 (531.2369238000001)
(3-fluorophenyl)-[(1S)-2-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanone
[(1R)-7-methoxy-9-methyl-1-(4-methylphenyl)sulfonyl-2-(phenylmethyl)-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]methanol
N-[(2S,3R,4R,5S,6R)-4-Hydroxy-6-(hydroxymethyl)-2-[(2S,3R,4S,5R)-1,2,4,5,6-pentahydroxyhexan-3-yl]oxy-5-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]acetamide
C20H37NO15 (531.2163092000001)
N-[(2S,3R,4R,5R)-4-[(2S,3R,4S,5R,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-1,3,5,6-tetrahydroxyhexan-2-yl]acetamide
C20H37NO15 (531.2163092000001)
N-[(2S,3R,4S,5R)-3-[(2S,3R,4S,5R,6R)-4,5-Dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-1,4,5,6-tetrahydroxyhexan-2-yl]acetamide
C20H37NO15 (531.2163092000001)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(1-hydroxy-2,4-diphenylbutan-2-yl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
N-[(2S,3R,4S,5R)-1,5,6-Trihydroxy-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyhexan-2-yl]acetamide
C20H37NO15 (531.2163092000001)
3-[[3-acetyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid
DO34
DO34 is a highly potent, selective and centrally active diacylglycerol lipase (DAGL) inhibitor, with an IC50 of 6 nM for DAGLα conversion of SAG to 2-AG, and an IC50 for DAGLβ.
DO34 analog
DO34 analog is a triazole DAGL(α) inhibitor extracted from patent WO2017096315 A1, compound 100.
Thymotrinan (TFA)
Thymotrinan (RGH-0205) TFA is a biologically active fragment of the naturally occurring thymus hormone thymopoietin and a immunomodulating peptide. Thymotrinan TFA exerts similar immunomodulatory activities to TP5 and to affect humoral as well as cellular responses[1].
Zamifenacin (fumarate)
Zamifenacin fumarate (UK-76654 fumarate) is a potent gut-selective muscarinic M3 receptor antagonist. Zamifenacin significantly reduces colonic motility in irritable bowel syndrome[1].